![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC44A5 |
Gene summary for SLC44A5 |
![]() |
Gene information | Species | Human | Gene symbol | SLC44A5 | Gene ID | 204962 |
Gene name | solute carrier family 44 member 5 | |
Gene Alias | CTL5 | |
Cytomap | 1p31.1 | |
Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q8NCS7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
204962 | SLC44A5 | RNA-P17T-P17T-2 | Human | Lung | IAC | 1.20e-03 | 6.47e-01 | 0.3371 |
204962 | SLC44A5 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.61e-08 | 9.20e-01 | 0.343 |
204962 | SLC44A5 | RNA-P17T-P17T-6 | Human | Lung | IAC | 5.58e-04 | 5.85e-01 | 0.3385 |
204962 | SLC44A5 | RNA-P17T-P17T-8 | Human | Lung | IAC | 2.31e-03 | 4.99e-01 | 0.3329 |
204962 | SLC44A5 | HTA12-23-1 | Human | Pancreas | PDAC | 2.25e-04 | 5.41e-01 | 0.3405 |
204962 | SLC44A5 | HTA12-25-1 | Human | Pancreas | PDAC | 2.41e-10 | 8.00e-01 | 0.313 |
204962 | SLC44A5 | HTA12-26-1 | Human | Pancreas | PDAC | 1.03e-14 | 7.87e-01 | 0.3728 |
204962 | SLC44A5 | HTA12-29-1 | Human | Pancreas | PDAC | 9.39e-39 | 8.57e-01 | 0.3722 |
204962 | SLC44A5 | HTA12-30-1 | Human | Pancreas | PDAC | 1.14e-02 | 8.13e-01 | 0.3671 |
204962 | SLC44A5 | HTA12-32-1 | Human | Pancreas | PDAC | 1.46e-03 | 9.05e-01 | 0.3624 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa052317 | Lung | IAC | Choline metabolism in cancer | 23/1053 | 98/8465 | 1.72e-03 | 9.66e-03 | 6.41e-03 | 23 |
hsa0523112 | Lung | IAC | Choline metabolism in cancer | 23/1053 | 98/8465 | 1.72e-03 | 9.66e-03 | 6.41e-03 | 23 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC44A5 | insertion | Nonsense_Mutation | novel | c.1097_1098insAAAGTACGT | p.Tyr366delinsTer | p.Y366delins* | protein_coding | TCGA-B5-A11V-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
SLC44A5 | insertion | Frame_Shift_Ins | novel | c.1281_1282insAGAAG | p.Glu428ArgfsTer43 | p.E428Rfs*43 | protein_coding | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
SLC44A5 | insertion | Frame_Shift_Ins | novel | c.1280_1281insCTATAGCATT | p.Glu428TyrfsTer4 | p.E428Yfs*4 | protein_coding | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
SLC44A5 | deletion | Frame_Shift_Del | novel | c.569delN | p.Asn190MetfsTer4 | p.N190Mfs*4 | protein_coding | TCGA-D1-A17U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | |||
SLC44A5 | SNV | Missense_Mutation | c.70N>T | p.Asp24Tyr | p.D24Y | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-BC-A217-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SLC44A5 | SNV | Missense_Mutation | c.1571C>A | p.Ala524Glu | p.A524E | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-CC-5259-01 | Liver | liver hepatocellular carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | ||
SLC44A5 | SNV | Missense_Mutation | c.2063N>C | p.Arg688Thr | p.R688T | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-DD-AACK-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
SLC44A5 | SNV | Missense_Mutation | c.1212N>T | p.Lys404Asn | p.K404N | protein_coding | tolerated(0.12) | possibly_damaging(0.826) | TCGA-EP-A3JL-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
SLC44A5 | SNV | Missense_Mutation | novel | c.1480G>T | p.Asp494Tyr | p.D494Y | protein_coding | deleterious(0.01) | benign(0.216) | TCGA-05-4398-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR | |
SLC44A5 | SNV | Missense_Mutation | c.359N>T | p.Lys120Met | p.K120M | protein_coding | deleterious(0) | possibly_damaging(0.827) | TCGA-05-4430-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |